Historique
Auteur P. DELUCA
Documents disponibles écrits par cet auteur (21)
Ajouter le résultat à votre sélection Affiner la recherche
R. PATTON ; P. DELUCA ; E. KANER ; D. NEWBURY-BIRCH ; T. PHILLIPS ; C. DRUMMOND | 2014
Dans Alcohol and Alcoholism (Vol.49, n°2, March-April 2014) Article : PériodiqueAim: The aim of the study was to explore the evidence base on alcohol screening and brief intervention for adolescents to determine age appropriate screening tools, effective brief interventions and appropriate locations to undertake these activ[...]
F. SCHIFANO ; J. CORKERY ; E. GILVARRY ; P. DELUCA ; A. OYEFESO ; A. H. GHODSE | 2005
Dans Human Psychopharmacology: Clinical and Experimental (Vol.20, n°5, July 2005) Article : PériodiqueBuprenorphine safety in overdose has been debated recently, but no mortality data related to this compound from the UK have been published. To gather together all of the buprenorphine mortality figures, a number of different sources have been ch[...]
O. CORAZZA ; F. SCHIFANO ; M. FARRE ; P. DELUCA ; Z. DAVEY ; C. DRUMMOND ; M. TORRENS ; Z. DEMETROVICS ; L. DI FURIA ; L. H. FLESLAND ; B. MERVO ; J. MOSKALEWICZ ; A. PISARSKA ; H. SHAPIRO ; H. SIEMANN ; A. SKUTLE ; C. PEZZOLESI ; P. VAN DER KREEFT ; N. SCHERBAUM | 2011
PériodiqueBased on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-[...]
F. SCHIFANO ; P. DELUCA ; A. BALDACCHINO ; T. PELTONIEMI ; N. SCHERBAUM ; M. TORRENS ; M. FARRE ; FLORES I. ; M. ROSSI ; D. EASTWOOD ; GUIONNET C. ; S. RAWAF ; L. AGOSTI ; L. DI FURIA ; BRIGADA R. ; A. MAJAVA ; H. SIEMANN ; LEONI M. ; TOMASIN A. ; ROVETTO F. ; A. H. GHODSE ; Psychonaut 2002 Research Group | 2006
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.30, n°4, 2006) Article : PériodiquePURPOSE: Only a few formal assessments of websites with drug-related contents have been carried out. We aimed here at fostering collection and analysis of data from web pages related to information on consumption, manufacture and sales of psycho[...]
Z. DAVEY ; F. SCHIFANO ; O. CORAZZA ; P. DELUCA ; Psychonaut Web Mapping Group | 2012
Dans Journal of Mental Health (Vol.21, n°4, August 2012) Article : PériodiqueBACKGROUND: "Legal highs" are becoming increasingly common features of the recreational drug market. The Internet has emerged as an important resource for technical and pharmacological knowledge in the absence of evidence-based literature, and f[...]
F. SCHIFANO ; J. CORKERY ; P. DELUCA ; A. OYEFESO ; A. H. GHODSE | 2006
Dans Journal of Psychopharmacology (Vol.20, n°3, 2006) Article : PériodiqueIn the last decade, a global trend of escalating ecstasy (MDMA, MDA, MDEA, MBDB) use was observed. Mentions on medical death certificates, last year's ecstasy use, number of drug offenders, seizures, prices and dosage levels figures were used fo[...]
E. KANER ; M. BLAND ; P. CASSIDY ; S. COULTON ; V. DALE ; P. DELUCA ; E. GILVARRY ; C. GODFREY ; N. HEATHER ; J. MYLES ; D. NEWBURY-BIRCH ; A. OYEFESO ; S. PARROTT ; K. A. PERRYMAN ; T. PHILLIPS ; J. SHEPHERD ; C. DRUMMOND | 2013
Dans British Medical Journal (Vol.346, n°7892, 26 January 2013) Article : PériodiqueObjective: To evaluate the effectiveness of different brief intervention strategies at reducing hazardous or harmful drinking in primary care. The hypothesis was that more intensive intervention would result in a greater reduction in hazardous o[...]
P. DELUCA ; Z. DAVEY ; O. CORAZZA ; L. DI FURIA ; M. FARRE ; L. H. FLESLAND ; M. MANNONEN ; A. MAJAVA ; T. PELTONIEMI ; M. PASINETTI ; C. PEZZOLESI ; N. SCHERBAUM ; H. SIEMANN ; A. SKUTLE ; M. TORRENS ; P. VAN DER KREEFT ; E. IVERSEN ; F. SCHIFANO | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : PériodiqueBACKGROUND: This paper presents the outcomes of the 2-year European Union funded Psychonaut Web Mapping Project which aimed at developing and implementing an integrated web mapping system to promptly identify and learn about novel psychoactive s[...]
C. DRUMMOND ; A. GUAL ; C. GOOS ; C. GODFREY ; P. DELUCA ; C. VON DER GOLTZ ; G. GMEL ; E. SCAFATO ; A. WOLSTENHOLME ; K. MANN ; S. COULTON ; E. KANER | 2011
Dans Addiction (Vol.106, Suppl.1, March 2011) Article : PériodiqueAIMS: A literature review of existing research on the prevalence of alcohol use disorders (AUDs) and availability of alcohol interventions in Europe was conducted. The review also explored what is known about the gap between need and provision o[...]
E. WADSWORTH ; C. DRUMMOND ; A. KIMERGARD ; P. DELUCA | 2017
Dans Human Psychopharmacology: Clinical and Experimental (Vol.32, n°3, May 2017) Article : PériodiqueObjective: The hidden Web is used for the anonymous sale of drugs, and with the UK Psychoactive Substances Act, 2016, implemented on May 26th 2016; it could increase as a platform for obtaining new psychoactive substances (NPS). This study aims [...]
Z. DAVEY ; O. CORAZZA ; F. SCHIFANO ; P. DELUCA ; Psychonaut Web Mapping Group | 2010
Dans Drugs and Alcohol Today (Vol.10, n°3, September 2010) Article : PériodiqueThe market in licit recreational drugs is continuing to grow, both in the UK and elsewhere, and the internet has been acknowledged as a key factor in enabling this rapid expansion over the last few years. This is particularly true of the recent [...]
F. SCHIFANO ; A. ALBANESE ; S. FERGUS ; J. L. STAIR ; P. DELUCA ; O. CORAZZA ; Z. DAVEY ; J. CORKERY ; H. SIEMANN ; N. SCHERBAUM ; M. FARRE ; M. TORRENS ; Z. DEMETROVICS ; A. H. GHODSE ; Psychonaut Web Mapping Group ; ReDNet Research Group | 2011
Dans Psychopharmacology (Vol.214, n°3, April 2011) Article : PériodiqueBACKGROUND Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; ‘meow meow’ and others) has been seen by some as a cheaper alterna[...]
A. R. WINSTOCK ; L. R. MITCHESON ; P. DELUCA ; Z. DAVEY ; O. CORAZZA ; F. SCHIFANO | 2011
Dans Addiction (Vol.106, n°1, January 2011) Article : PériodiqueAIMS: Mephedrone (4-methylmethcathinone) is a novel synthetic stimulant drug that has recently become popular in the United Kingdom and elsewhere in Europe. It has a short history of human consumption and little is known about its prevalence and[...]
A. R. WINSTOCK ; W. LAWN ; P. DELUCA ; R. BORSCHMANN | 2016
Dans Drug and Alcohol Review (Vol.35, n°2, March 2016) Article : PériodiqueIntroduction and Aims: To assess the prevalence of use and subjective effect profile of methoxetamine among a group of polydrug users. Design and Methods: Cross-sectional, anonymous, online survey of UK-based polydrug users was conducted. Prev[...]
A. K. ROSE ; H. WINFIELD ; J. H. JENNER ; A. OYEFESO ; T. S. PHILLIPS ; P. DELUCA ; K. A. PERRYMAN ; C. HERIOT-MAITLAND ; S. GALEA ; S. CHEETA ; V. SAUNDERS ; C. DRUMMOND | 2012
Dans Journal of Substance Use (Vol.17, n°5-6, October-November 2012) Article : PériodiqueBackground: To map and contact all alcohol treatment services in England offering Tier 2, 3 and 4 interventions and describe the characteristics of their service-users. Methods: A national cross-sectional survey of alcohol treatment providers i[...]
